Concepedia

Dong‐Wan Kim

DK

Statistics

Publications

264

Citations

32.2K

H-Index

72

Active since

1999

Affiliations

Seoul National University Hospital(Current)

Seoul National University

Samsung Medical Center

Sungkyunkwan University

Asan Medical Center

Dong‐Wan Kim is an author at Seoul National University Hospital specializing in oncology, medicine, and pharmacology.

Publications per year

1999–2025

264

Publications

264

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Dong‐Wan Kim, Enriqueta Felip et al. · The Lancet · 2015 · 6.5K citations

Medicine, Oncology, Pharmacology +14

Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Solange Peters, D. Ross Camidge, Alice T. Shaw et al. · New England Journal of Medicine · 2017 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +16

Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes

Ki Tae Nam, Dong‐Wan Kim, Pil J. Yoo et al. · Science · 2006 · 1.9K citations

Natural Sciences, Materials Engineering, Materials Science +17

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

D. Ross Camidge, Yung‐Jue Bang, Eunice L. Kwak et al. · The Lancet Oncology · 2012 · 1.3K citations

Medicine, Oncology, Pharmacology +15

First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer

Alice T. Shaw, Todd M. Bauer, Filippo de Marinis et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 264